Advertisement

PentaVision

Retinal Physician

Article

How I Work With My Patients on Complement Inhibitor Therapy for GA

Some patients decide to go forward with treatment and some do not, but I find it important to educate each patient about the disease process and their options.

By: Margaret Chang, MD
Retinal Physician February 7, 2025
5 Key Takeaways

  • 1

    Education about geographic atrophy (GA) and treatment options is crucial for patient decision-making.

  • 2

    FDA-approved intravitreal complement inhibitors for GA require regular treatment visits every 1 to 2 months.

  • 3

    Treatment can slow GA progression but does not restore lost vision or completely halt disease advancement.

  • 4

    Involving family members in discussions helps patients manage information overload and make informed choices.

  • 5

    Emerging therapies for GA show promise, but current FDA-approved options are significant for previously untreatable cases.